These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 23913253

  • 1. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
    Makar RS, Zhukov OS, Sahud MA, Kuter DJ.
    Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253
    [Abstract] [Full Text] [Related]

  • 2. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R.
    Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
    [Abstract] [Full Text] [Related]

  • 3. Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center.
    González KJ, Zuluaga SO, DaRos CV, Rodríguez PP, Martí AC.
    Ann Hematol; 2017 Mar; 96(3):507-508. PubMed ID: 27975127
    [No Abstract] [Full Text] [Related]

  • 4. Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia.
    Al-Samkari H, Kuter DJ.
    Am J Hematol; 2018 Dec; 93(12):1501-1508. PubMed ID: 30187942
    [Abstract] [Full Text] [Related]

  • 5. Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.
    Gudbrandsdottir S, Frederiksen H, Hasselbalch H.
    Platelets; 2012 Dec; 23(6):423-9. PubMed ID: 22185370
    [Abstract] [Full Text] [Related]

  • 6. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
    Mazza P, Minoia C, Melpignano A, Polimeno G, Cascavilla N, Di Renzo N, Specchia G.
    Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
    [Abstract] [Full Text] [Related]

  • 7. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
    Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Pérault-Pochat MC, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P.
    Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
    [Abstract] [Full Text] [Related]

  • 8. The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.
    Mahévas M, Fain O, Ebbo M, Roudot-Thoraval F, Limal N, Khellaf M, Schleinitz N, Bierling P, Languille L, Godeau B, Michel M.
    Br J Haematol; 2014 Jun; 165(6):865-9. PubMed ID: 24725224
    [Abstract] [Full Text] [Related]

  • 9. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T, Harada Y, Matsubara E, Suzuki T, Oyama T, Kasai M, Uchida T, Ogura M.
    J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038
    [Abstract] [Full Text] [Related]

  • 10. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
    Mitchell WB, Pinheiro MP, Boulad N, Kaplan D, Edison MN, Psaila B, Karpoff M, White MJ, Josefsson EC, Kile BT, Bussel JB.
    Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.
    Agnelli Giacchello J, Valeri F, Boccadoro M, Borchiellini A.
    Eur J Haematol; 2018 Mar; 100(3):304-307. PubMed ID: 29243329
    [Abstract] [Full Text] [Related]

  • 15. Thrombopoietin Receptor Agonists in Children with Immune Thrombocytopenia: A New Therapeutic Era.
    Lassandro G, Palladino V, Vecchio GCD, Palmieri VV, Corallo PC, Faienza MF, Giordano P.
    Endocr Metab Immune Disord Drug Targets; 2021 Mar; 21(3):397-406. PubMed ID: 32473624
    [Abstract] [Full Text] [Related]

  • 16. Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study.
    Neunert C, Despotovic J, Haley K, Lambert MP, Nottage K, Shimano K, Bennett C, Klaassen R, Stine K, Thompson A, Pastore Y, Brown T, Forbes PW, Grace RF, Pediatric ITP Consortium of North America (ICON).
    Pediatr Blood Cancer; 2016 Aug; 63(8):1407-13. PubMed ID: 27135461
    [Abstract] [Full Text] [Related]

  • 17. Moving towards a new era in the management of chronic immune thrombocytopenia.
    Wadenvik H, Olsson B.
    Ann Hematol; 2010 Jul; 89 Suppl 1():87-93. PubMed ID: 20339846
    [Abstract] [Full Text] [Related]

  • 18. Thrombopoietin receptor agonists in hereditary thrombocytopenias.
    Rodeghiero F, Pecci A, Balduini CL.
    J Thromb Haemost; 2018 Sep; 16(9):1700-1710. PubMed ID: 29956472
    [Abstract] [Full Text] [Related]

  • 19. Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice.
    Ptushkin VV, Vinogradova OY, Pankrashkina MM, Chernikov MV, Arshanskaya EG, Tkachenko NE.
    Ter Arkh; 2018 Aug 17; 90(7):70-76. PubMed ID: 30701925
    [Abstract] [Full Text] [Related]

  • 20. Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.
    Atkinson K.
    Clin J Oncol Nurs; 2019 Apr 01; 23(2):212-216. PubMed ID: 30880797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.